Chih Kang Ke
Director/Board Member presso TAHO PHARMACEUTICALS LTD
Profilo
Chih Kang Ke is an Independent Director at TAHO Pharmaceuticals Ltd.
He previously worked as a Managing Director & Investment Director at Global Strategic Investment Management, Inc., an Independent Director at Easywell Biomedicals, Inc., an Independent Director at MACHVISION, Inc., and a Member-Supervisory Board at PharmaDax Inc.
Posizioni attive di Chih Kang Ke
| Società | Posizione | Inizio |
|---|---|---|
| TAHO PHARMACEUTICALS LTD | Director/Board Member | - |
Precedenti posizioni note di Chih Kang Ke
| Società | Posizione | Fine |
|---|---|---|
| EASYWELL BIOMEDICALS, INC. | Director/Board Member | - |
| MACHVISION INC. | Director/Board Member | - |
| PHARMADAX INC. | Director/Board Member | - |
| Global Strategic Investment Management, Inc. | Chief Executive Officer | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| EASYWELL BIOMEDICALS, INC. | Health Technology |
| MACHVISION INC. | Producer Manufacturing |
| Aziende private | 3 |
|---|---|
| Global Strategic Investment Management, Inc. | Finance |
PharmaDax Inc.
 PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan. | Health Technology |
TAHO Pharmaceuticals Ltd.
 TAHO Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Taho Pharmaceuticals Ltd. engages in the research and development of pharmaceutical products. Its Technology Platform products are the Transepithelial Delivery System, Transdermal DDS, Transmucosal SSD, and Bio-Revie. The firm's Research & Development products include medicines for migraine, alzheimer's disease, hyperactivity disorder, and nausea caused by chemotherapy. The company was founded on July 7, 2010 and is headquartered in Taipei, Taiwan. | Health Technology |
- Borsa valori
- Insiders
- Chih Kang Ke
